This article shares the exact recipe that worked, the evidence behind it, and when it might backfire
The SELECT study on Novos Wegovy showed a c20% reduction in the risk of heart disease (heart attack, stroke or cardiovascular death) when taken for 5 years, compared to those who did not
Still, the comparison with earlier global access campaigns for HIV, tuberculosis, malaria, and hepatitis is not just rhetoric
This is a significant milestone because it shows semaglutide is not simply helping people lose weight
Conditions that typically exclude GLP-1 candidacy - and that Omzo's clinical intake process is designed to screen for - include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), a history of pancreatitis, and known hypersensitivity to semaglutide or any component of the medication
A clear brand logo can make it easier to verify official resources